To evaluate the effectiveness and safety of catheter ablation of frequent symptomatic PVCs in the pediatric population as first-line therapy compared with antiarrhythmic drugs.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
124
Biosense Webster: NAVI-STAR ThermoCool, NAVI-STAR® RMT ThermoCool
Antiarrhythmic therapy of premature ventricular complexes Metoprolol 12-50 mg
Verapamil 20-240 mg
Research Clinical Institute of Pediatrics, N.I. Pirogov Russian National Research Medical University
Moscow, Russia
RECRUITINGState Research Institute of CIrculation Pathology Novosibirsk, Russian Federation
Novosibirsk, Russia
RECRUITINGThe presence of premature ventricular complexes ≥ 300 according to the 24-hour Holter ECG monitoring
Time frame: 12 months
Complications
Time frame: 12 months
Left ventricle diameter
Time frame: 12 months
Right ventricle diameter
Time frame: 12 months
Premature ventricular complexes burden according to the 24- hour Holter ECG
Time frame: 12 months
Ventricular tachycardia according to the 24- hour Holter ECG
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.